Adjunctive Medical Therapy with Oral Silodosin after Shock Wave Lithotripsy of Lower Ureteral Stone: A randomized controlled study

Phase 4

Completed

• Conditions: ower ureteral stone after ESWL; Lower ureteral stone after ESWL; Renal and Urogenital - Other renal and urogenital disorders

• Registration Number: ACTRN12611000573954
• Lead Sponsor: Chung Jing Wang

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-06-03
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 45

Inclusion Criteria

Stones were calculated according to the diameter along the ureteral axis, and the size was between 4mm and 9 mm. All patients underwent ESWL were enrolled in the study after providing informed consent.

Exclusion Criteria

urinary tract infections, high-grade hydronephrosis, diabetes, ulcers, or a history of hypersensitivity to a-blockers, ureteral stricture and pregnant women,history of spontaneous stone expulsion, hypotension, or those found to have systolic blood pressure lower than 110 mmHg

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
the expulsion time[reported by patients or stone presence and characteristics were diagnosed through x-ray of kidney-ureter-bladder, abdominal ultrasonography, intravenous urography and nonenhenced CT at 2 weeks];the expulsion rate[stone presence and characteristics were diagnosed through x-ray of kidney-ureter-bladder, abdominal ultrasonography, intravenous urography and nonenhenced CT at 2 weeks]

Secondary Outcome Measures

Name	Time	Method
analgesic consumption[recorded by patient diaries for 2 weeks];lower urinary tract symptoms[IPSS questionnaire at 2 weeks];colic episodes[recorded by patient diaries for 2 weeks];adverse effects[Dizziness,postural hypotension recorded by patient diaries daily for 2 weeks]